title: Decreasing pancreatic toxicity of tacrolimus by dosage reduction.
authors.affiliation: Department of Transplant Surgery, Nagoya Daini Red Cross Hospital, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Uchida
authors.forename: Y
authors.initials: Y
authors.lastname: Tominaga
authors.forename: T
authors.initials: T
authors.lastname: Haba
authors.forename: A
authors.initials: A
authors.lastname: Katayama
authors.forename: T
authors.initials: T
authors.lastname: Ichimori
authors.forename: K
authors.initials: K
authors.lastname: Yamada
authors.forename: Y
authors.initials: Y
authors.lastname: Hibi
authors.forename: O
authors.initials: O
authors.lastname: Uemura
authors.forename: K
authors.initials: K
authors.lastname: Morozumi
authors.forename: H
authors.initials: H
authors.lastname: Takagi
mesh_terms: D000284:Administration, Oral; D001786:Blood Glucose / Q000378:metabolism; D003920:Diabetes Mellitus / Q000139:chemically induced* / Q000517:prevention & control; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D018149:Glucose Intolerance / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D016030:Kidney Transplantation / Q000276:immunology*; D008657:Metabolic Clearance Rate; D011239:Prednisolone / Q000627:therapeutic use; D012044:Regression Analysis; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics
chemical_list: D001786:Blood Glucose; D007166:Immunosuppressive Agents; D011239:Prednisolone; D016559:Tacrolimus